Name | Title | Contact Details |
---|
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders.
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Zacharon is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Skingenix is a Arcadia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases.